Plain-English translation of NCT06210022 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Epilepsy research guide →This research study is looking at how focal cryptogenic epilepsy — a type of epilepsy that starts in one area of the brain and has no clear cause — affects thinking and memory. Researchers want to understand whether people have cognitive problems depending on how well their seizures respond to anti-seizure medications. You'll have brain wave tests (called EEGs), thinking and memory tests, and physical exams to help answer these questions.
Doctors know that epilepsy can sometimes affect thinking and memory, but they don't fully understand why some people struggle with these problems while others don't. This study will help researchers figure out whether seizure control and medication choices make a difference in how epilepsy impacts your brain function.
You likely qualify if…
You likely don't qualify if…
If you have drug-resistant or newly diagnosed epilepsy, you'll visit the clinic at baseline and then again at 6 months and 12 months. At each visit, a neuropsychologist will give you thinking and memory tests, a doctor will examine you, and you'll have a 20-minute brain wave recording (EEG). If your seizures are well-controlled on medication, you'll have similar visits at baseline and at one year. Throughout the study, researchers will track your seizure frequency and medications in a database.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Italy